Substitution or deletion mutations between nt 54 and 70 in the 59 non-coding region of dengue type 2 virus produce variable effects on virus viability
|
|
- Gavin Mosley
- 5 years ago
- Views:
Transcription
1 Journal of General Virology (2007), 88, DOI /vir Short Communication Correspondence Vijittra Leardkamolkarn Substitution or deletion mutations between nt 54 and 70 in the 59 non-coding region of dengue type 2 virus produce variable effects on virus viability Wipawan Sirigulpanit, 1 Richard M. Kinney 2 and Vijittra Leardkamolkarn 1 1 Department of Anatomy and Center for Vectors and Vector-Borne Diseases, Faculty of Science, Mahidol University, Bangkok 10400, Thailand 2 Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, US Department of Health and Human Services, Public Health Service, Fort Collins, CO 80522, USA Received 9 August 2006 Accepted 17 February 2007 A C57U nucleotide mutation in a predicted RNA stem structure (nt 11 16/56 61) of the 59 non-coding region (59NCR) of dengue 2 (DEN-2) virus is partially attenuating, but unstable during serial passage of certain candidate DEN-2 PDK-53-based vaccine viruses containing this mutation. Here, 11 different mutations (one or more point substitution and/or deletion) between nt 54 and 70 in the 59NCR of the pd2/ic-30p-a (16681) infectious clone are described. Four mutants were infectious. Three mutants with single point substitutions replicated well in cell culture and exhibited variable neurovirulence in mice. Constructs containing multiple substitutions or any deletions failed to produce infectious viruses. Unexpectedly, a double C57U+G58C mutant replicated as efficiently as D2/IC-30P-A virus, and was more neurovirulent for newborn ICR mice. Thus, despite its predicted additional disruption of the RNA stem structure, the engineered contiguous secondary G58C mutation caused reversion of the partially attenuated phenotype caused by the 59NCR-C57U mutation. Dengue viruses are flaviviruses (genus Flavivirus, family Flaviviridae) that are transmitted to humans principally by Aedes aegypti or Aedes albopictus mosquitoes in tropical regions of the world. Based on immunological studies, dengue viruses are divided into four distinct antigenic serotypes: DEN-1, -2, -3 and -4. The disease caused by DEN virus infection ranges from a non-specific viral syndrome to severe and often fatal dengue haemorrhagic fever/dengue shock syndrome. DEN-2 is the most prevalent serotype that has been identified in outbreaks. DEN viruses cause more than 100 million cases of infection and an estimated deaths worldwide each year (Gubler, 1998). An effective vaccine against dengue is not yet available. The DEN virus genome is a single-stranded, positivesense RNA that is approximately 11 kb in length. It contains a type I cap at the 59 end, but lacks a 39-end poly(a) tail. The genome organization is 59 non-coding region (59NCR) capsid protein premembrane (prm)/ membrane protein envelope (E) protein non-structural protein 1 (NS1) NS2A NS2B NS3 NS4A NS4B NS5 39NCR (Lindenbach & Rice, 2003). The 59NCRs of flaviviruses and several other positive-strand RNA viruses are predicted to form functional secondary RNA structures (Brinton & Dispoto, 1988). These structures can interact with cellular or viral proteins to regulate viral RNA translation (Ali & Siddiqui, 1995), RNA transcription and packaging (Guesdon et al., 2001; Kuhn et al., 2002). 59NCR sequences may also interact with downstream sequences, particularly 39NCR sequences, in the viral genome during virus replication (Alvarez et al., 2005; You et al., 2001). The functional significance of the 59NCR of DEN-4 virus has been demonstrated by the attenuating nature of mutations in this region, including changes that disrupt predicted base pairing (Cahour et al., 1995). A C57U mutation in the 96 nt long 59NCR of the candidate DEN-2 PDK-53 vaccine virus has been associated with viral attenuation (Butrapet et al., 2000; Kinney et al., 1997). The phenotypic markers of attenuation of the PDK-53 virus, which was derived from wild-type DEN virus, are encoded by the three mutations NS1-Gly Asp PDK-53, 59NCR-C57U and NS3-Glu250Val, in order of dominance of effect on virus replication in vitro and attenuation of neurovirulence for newborn mice (Butrapet et al., 2000). The 59NCR-C57U mutation contributes to the PDK-53 viral phenotypes of small plaque size, decreased replication in C6/36 cells and attenuation of neurovirulence for mice (Butrapet et al., 2000). The 59NCR-57 locus lies within a predicted 6 bp stem structure consisting of nt and (Butrapet et al., 2000). This stem structure is one of several stems in a larger predicted 59 structure, designated SLA and consisting of nt 1 70, which has recently been shown to be recognized by the viral RNA polymerase (NS5) and to participate in cyclization of the genome through Printed in Great Britain
2 Effect of mutations in the 59NCR of DEN-2 virus interaction with the 39-end sequence, thereby promoting minus-strand RNA synthesis in D2/IC-30P-A clonederived DEN virus (Filomatori et al., 2006). Presumably, the C57U mutation impairs this function in PDK-53 virus. Serial in vitro passage of chimeric DEN viruses expressing the prm/e gene region of DEN-1, -2, -3 or -4 virus in the genetic background of PDK-53 virus has demonstrated high genetic stability of the NS1-53-Asp and NS3-250-Val loci. However, these chimeric viruses, as well as the PDK- 53 virus itself, showed varying propensities for 59NCR- U57C reverse mutation during serial passage. The extent of reversion in these viruses was recently examined quantitatively (Butrapet et al., 2006). The present study was undertaken to determine whether other mutations near nt 57 in the 59NCR could attenuate wild-type DEN virus. Such mutations could prove useful in designing live-attenuated DEN vaccine viruses. We engineered 11 different mutations, each containing one or more point substitution and/or deletion (Table 1), into the 59NCR of the DEN virus-specific infectious cdna clone pd2/ic-30p-a by using standard in vitro mutagenesis procedures. Deletion or multiple point-substitution mutations in the 59NCR of viable, attenuated mutant viruses should resist reversion to wild-type sequence. We considered the planned double C57U+G58C mutation, with predicted greater destabilization of the stem structure, as a potentially more attenuating and reversion-resistant locus in a viable, clone-derived virus. Several other single point mutations were engineered to begin to examine the uniqueness of the 59NCR-C57U attenuating effect. DEN variants were derived by transfection of LLC-MK 2 cells with viral genomic RNA transcribed from plasmid DNA as described previously (Kinney et al., 1997). RNA transcripts of the single point-mutated plasmids pd2/ic- 55, -57, -60 and -69, as well as the double mutant pd2/ic- 5758, yielded fully infectious viruses, as indicated by the expression of immunofluorescence assay (IFA)-detectable DEN-2 viral antigen in 100 % of cells in the transfected cell culture following 4 7 days incubation (Table 1). In our non-optimized transfection experiments with pd2/ic- 30P-A clone-transcribed RNA, IFA-detectable DEN-2 viral antigen was detected routinely in a minor fraction of cells in the transfected culture during the first 2 days after electroporation (unpublished data), and the extent of IFA positivity has been a reliable indicator of clone-derived viral viability in our laboratory. The pd2/ic-v5 clone and D2/IC-V5 virus reported previously (Butrapet et al., 2000) were utilized in the current study and, for clarity, their designations are changed here to clone pd2/ic-57 and D2/ IC-57 virus, respectively. Rescued viruses were amplified once more in LLC-MK 2 cells, and the complete genomes (except for the 59- and 39-terminal primer target sequences) of the resulting virus seeds were sequenced following cdna amplification by RT-PCR. The single and double deletionmutant plasmids pd2/ic-d57 and pd2/ic-d5758 produced crippled, replication-deficient viruses that resulted in IFAdetectable DEN-2 antigen in approximately 5 and 10 % of transfected cells in the cultures, respectively, in four separate experiments. The remaining five mutations engineered into plasmids pd2/ic-d62/63 (deletion of nt 62, substitution at nt 63), -5760, -5661, -d5759 and -d5661 were Table 1. Mutations engineered into the 59NCR of DEN-2 virus 5 NCR plasmid mutant IFA-detectable DEN-2 antigen (%)* DEN-2 genomic nucleotide positiond pd2/ic-30p-ad 100 C A A C G T A G T T C T A A C A G pd2/ic C A A T G T A G T T C T A A C A G pd2/ic C G A C G T A G T T C T A A C A G pd2/ic C A A C G T G G T T C T A A C A G pd2/ic C A A T C T A G T T C T A A C A G pd2/ic C A A C G T A G T T C T A A C T G pd2/ic C A A T C C G G T T C T A A C A G pd2/ic C A G T C C G A T T C T A A C A G pd2/ic-d62/63 0 C A A C G T A G A C T A A C A G pd2/ic-d57 5 C A A G T A G T T C T A A C A G pd2/ic-d C A A T A G T T C T A A C A G pd2/ic-d C A A A G T T C T A A C A G pd2/ic-d C A T T C T A A C A G *100 %, All cells in the transfected LLC-MK 2 culture expressed DEN-2 antigen; 0 %, DEN-2 antigen was not detected in the transfected cell culture. DUnderlined letters indicate nucleotide substitutions; indicates deletion of the nucleotide at the indicated position. Nucleotides (shown in bold) form a predicted stem structure with nt Plasmid cdna (T), rather than viral RNA (U), nucleotides are shown. dinfectious cdna clone of wild-type DEN virus (Kinney et al., 1997). Described previously as plasmid D2/IC-V5 (Butrapet et al., 2000)
3 W. Sirigulpanit, R. M. Kinney and V. Leardkamolkarn considered lethal, because they failed to yield infectious viruses in five attempts. These results indicated that mutations involving certain 1 or 2 nt substitutions between nt 54 and 70 were well tolerated and resulted in viruses of high infectivity. However, all of the engineered deletion mutations, as well as those substitutions involving more than 2 nt, failed to yield infectious viruses. The results agree with a previous report showing that multiple contiguous deletions between nt 50 and 72 in the 59NCR of DEN-4 virus are fatal for the virus (Cahour et al., 1995). Viable clone-derived viruses were analysed for plaque size and replication in LLC-MK 2 cells and for replication in C6/36 cells, as described previously (Butrapet et al., 2000). At 9 days after infection, the mean plaque diameters (Table 2) of D2/IC-30P-A virus and D2/IC-69 virus were equivalent ( mm) (P.0.05, Student s t-test). D2/ IC-55 and -60 viruses produced significantly smaller plaques with a mean diameter of 2.5 mm (P,0.05), which was similar to the plaque size reported previously for D2/IC-57 virus (Butrapet et al., 2000). The D2/IC-5758 virus had a statistically significantly larger mean plaque size than the D2/ IC-30P-A virus (P,0.05). All of these viruses produced plaques that were much larger than the pinpoint (,1 mm) plaques of the candidate DEN-2 PDK-53 vaccine virus included in the same assays (data not shown). All three of the 59NCR-C57U, NS1-Gly53Asp and NS3-Glu250Val mutations have been shown to contribute independently, and additively, to the reduced plaque size of PDK-53 virus (Butrapet et al., 2000). The D2/IC-d57 and -d5758 viruses failed to produce plaques, even by 2 weeks post-infection (data not shown). Virus growth curves were determined in LLC-MK 2 or C6/ 36 cells infected at an m.o.i. of approximately p.f.u. per cell. Aliquots of culture medium were removed at 48 h intervals for 12 days. Plaque titrations were performed in confluent monolayers of Vero or LLC-MK 2 cells as described previously (Huang et al., 2000; Miller & Mitchell, 1986). Viruses D2/IC-30P-A, D2/IC-55, -57, -60, and -69 replicated well to high peak titres of p.f.u. ml 21 at days after infection of LLC-MK 2 cells (Fig. 1a). D2/IC-60 virus replicated more slowly than the other viruses between days 2 and 8 after infection, but attained a similarly high titre by days The clone-derived viruses showed variable replication in C6/36 cells (Fig. 1b). D2/IC-30P-A, -60, and -69 viruses replicated to peak titres of p.f.u. ml 21 at day 8 after infection, although replication of D2/IC-60 virus appeared to be slightly delayed in these cells as well. D2/IC-57 and -55 viruses exhibited restricted growth that was characterized by 100- and 10-fold decreases in peak titres, respectively, relative to the replication of D2/IC-30P-A virus in C6/36 cells. The peak titres of these two viruses also occurred at day 8 after infection. DEN-2 PDK-53 virus replicated to p.f.u. ml 21 after 8 days growth in C6/36 cells (data not shown). The severely crippled replicative phenotype of the DEN-2 PDK-53 virus in C6/36 cells is caused by the 59NCR-C57U and NS1-Gly53Asp mutations, both of which have been shown to inhibit virus replication independently, as well as additively when both mutations were engineered together into the DEN virus genome (Butrapet et al., 2000). Wild-type DEN virus routinely causes % mortality in newborn ICR mice challenged intracranially (i.c.) with 10 4 p.f.u. virus, whereas the candidate PDK-53 vaccine virus is reproducibly attenuated in this model (Butrapet et al., 2000; Huang et al., 2000, 2003; Kinney et al., 1997). Attenuation of neurovirulence for ICR mice is Table 2. Plaque size and neurovirulence of DEN-2 59NCR mutant viruses Abbreviations: MST, mean survival time; NA, not applicable. Virus Plaque size (mm) (mean±sd)* Mortality (%)D MST±SD (days) Body mass (g) (mean±sd)d Diluent NA 0.00 NA 16.2±1.9 D2/IC-30P-A 3.0± ± ±1.9 D2/IC ± ±4.2 D2/IC ± ± ±1.6 D2/IC ± ± ±1.0 D2/IC ±0.3# ± ±1.3 D2/IC ± ± ±1.9 *Diameter of 20 randomly selected plaques. Dn532 mice per group, except for D2/IC-57 virus (n516). dbody mass of surviving mice 3 weeks after infection. Plaque size and neurovirulence results are from a previous study (Butrapet et al., 2000). Mean body mass of surviving mice was significantly lower (P,0.001, Student s t-test) than that of diluentinoculated control mice 3 weeks after infection (Butrapet et al., 2000). Significantly smaller than mean plaque size of D2/IC-30P-A virus (P,0.05, Student s t-test). #Significantly greater than mean plaque size of D2/IC-30P-A virus (P,0.05, Student s t-test) Journal of General Virology 88
4 Effect of mutations in the 59NCR of DEN-2 virus Fig. 1. Growth curves of D2/IC-30P-A virus (clone-derived, wildtype DEN virus) and its viable clone-derived mutants in LLC-MK 2 (a) and C6/36 (b) cells. Cells were infected at an approximate m.o.i. of p.f.u. per cell. D2/IC-57 is a previously described virus (Butrapet et al., 2000). m, D2/IC-30P-A; $, D2/ IC-57; ¾, D2/IC-55;, D2/IC-60; #, D2/IC-5758; g, D2/IC-69. * caused by the NS1-Gly53Asp and 59NCR-C57U mutations (Butrapet et al., 2000). More recently, the NS3-Glu250Val mutation was also found to contribute to the attenuated phenotype of PDK-53 virus in the more DEN-2 virussensitive Swiss Webster mouse model (Huang et al., 2005). In the present study, the mutant 59NCR viruses were tested for neurovirulence in newborn ICR mice. In two separate experiments, groups of 16 mice were inoculated i.c. with 10 4 p.f.u. clone-derived D2/IC virus and observed for 35 days for morbidity, paralysis and/or death. All mice surviving for 21 days after infection were weighed individually on that day. The pooled results (32 mice per group) from the two experiments are shown in Table 2. Previously published data for D2/IC-57 virus (n516 mice) are shown for comparison (Butrapet et al., 2000). The D2/IC-30P-A and D2/IC-60 viruses resulted in % mortality, with a mean survival time (MST) of 13.6 and 15.8 days, respectively. Because we previously identified only % mortality (MST of 21.7 days) in newborn ICR mice challenged i.c. with D2/IC-57 virus, the 87.5 %, wild-type level of mortality in mice challenged with D2/IC-5758 virus was unexpected (Table 2). Mice succumbing to challenge with this virus had the lowest MST (9.9 days), and the survivors at 21 days exhibited the lowest mean body mass (9.8 g), of all mouse groups tested. Viruses D2/IC-55 and D2/IC-69 showed lower levels of mortality of 50 and % (MSTs of 16.8 and 19.2 days), respectively, compared with D2/IC- 30P-A virus. At 21 days after i.c. infection, the surviving mice in all of the virus-challenged groups exhibited a significantly lower mean body mass than the diluentinoculated control mice (P,0.001, Student s t-test). Even though the ICR mouse model of neurovirulence for DEN virus is fairly insensitive, the D2/IC-69 virus appeared to be partially attenuated for neurovirulence, although it exhibited the robust replication phenotype of the D2/IC-30P-A virus in terms of plaque size and replication in LLC-MK 2 and C6/36 cells. The A69U mutation is located at the leading end of the first stem (nt 4 9/64 69), situated at the base of the predicted large SLA structure (Filomatori et al., 2006). This A69U substitution has been identified in wild-type DEN-2 virus and was reported to constitute a significant genetic marker in differentiating between South-East Asian DEN-2 strains and DEN-2 strains of the American genotype (Leitmeyer et al., 1999). Given the apparent partial attenuation of mouse neurovirulence afforded by the A60U mutation and the robust replication of the D2/IC-69 virus in both mammalian (LLC-MK 2 ) and mosquito (C6/36) cell cultures, it might be fruitful to investigate a combination of this mutation with another attenuating 59NCR mutation, such as the C57U mutation, in a potentially attenuated double mutant that might resist complete genetic reversion in the 59NCR more readily during viral passage. D2/IC-57 virus exhibited 50 % morbidity in ICR mice. Although it is difficult to interpret such a result in the ICR model, it is possible that D2/IC-55 is slightly attenuated for neurovirulence. This virus did exhibit decreased replicative ability in C6/36 cells (although not to the extent of D2/IC-55 virus) and smaller plaque size, relative to D2/IC-30P-A virus. The A55G mutation might be another possible candidate for inclusion in an attenuated virus containing a double mutation in the 59NCR. The D2/IC-60 virus was reproducibly less robust during the first 6 8 days of replication in LLC-MK 2 cells in two independent experiments, but replicated well in C6/36 cells and was fully neurovirulent for mice. As we were unable to derive infectious viruses from the plasmid constructs containing one or more deletion mutation or more than two nucleotide substitutions, a defect in viral protein synthesis that might have prevented virus replication was suspected. The capacity of the RNA mutants to direct protein synthesis was examined in the rabbit reticulocyte lysate system in the presence of [ 35 S]Met. The translation products were analysed by SDS-PAGE (10 % gels) and translation efficiencies were determined by measuring incorporation of acid-precipitated [ 35 S]Met. All
5 W. Sirigulpanit, R. M. Kinney and V. Leardkamolkarn of the RNA mutants were translated efficiently to variable extents, with [ 35 S]Met incorporation ranging from to 2.13-fold relative to the pd2/ic-30p-a RNA transcript (data not shown). The results obtained failed to show an obvious impact of mutation on translation efficiency. Nevertheless, this finding is in agreement with a recent study demonstrating that the 59NCR SLA structure functions in minus-strand RNA synthesis, rather than RNA translation (Filomatori et al., 2006). Interestingly, the D2/IC-5758 mutant, which was expected to be less neurovirulent in mice than the D2/IC-V5 mutant, yielded unexpected results. RNA secondary-structure prediction of the 59NCR of each mutant DEN-2 virus was performed with the Mfold program (Zuker, 2003). The predicted stem structure formed by nt and was more perturbed in the D2/IC-5758 mutant than in the D2/IC-57 virus, as expected by the incorporation of the G58C mutation in addition to the partially attenuating 59NCR-C57U mutation in this stem structure (data not shown). Rather than exhibiting more pronounced attenuation markers, the D2/IC-5758 mutant replicated as well as the wild-type virus in both LLC-MK 2 and C6/36 cell cultures, exhibited a large plaque size and appeared to be more neurovirulent for newborn ICR mice than the wild-type (D2/IC-30P-A) virus. Thus, despite its predicted additional disruption of the RNA stem structure, the engineered contiguous secondary G58C mutation caused reversion of the partially attenuated phenotype caused by the 59NCR-C57U mutation. This observation is particularly relevant for candidate live-attenuated, chimeric DEN virus and other flavivirus vaccines based on the genetic background of the attenuated DEN-2 PDK-53 virus. Genetic analyses of such vaccine virus seeds would be able to verify the apparent absence of potentially compensatory secondary mutations in the 59NCR, as well as a low level or absence of reversion at the 59NCR-57U locus. Acknowledgements This study was supported by the Royal Golden Jubilee PhD Programme of Thailand Research Fund (RGJ/PHD/2541) and Thailand- Tropical Diseases Research Programme (T2), National Center for Genetic Engineering and Biotechnology. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. References Ali, N. & Siddiqui, A. (1995). Interaction of polypyrimidine tractbinding protein with the 59 noncoding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of translation. J Virol 69, Alvarez, D. E., Lodeiro, M. F., Luduena, S. J., Pietrasanta, L. I. & Gamarnik, A. V. (2005). Long-range RNA-RNA interactions circularize the dengue virus genome. J Virol 79, Brinton, M. A. & Dispoto, J. H. (1988). Sequence and secondary structure analysis of the 59-terminal region of flavivirus genome RNA. Virology 162, Butrapet, S., Huang, C. Y., Pierro, D. J., Bhamarapravati, N., Gubler, D. J. & Kinney, R. M. (2000). Attenuation markers of a candidate dengue type 2 vaccine virus, strain (PDK-53), are defined by mutations in the 59 noncoding region and nonstructural proteins 1 and 3. J Virol 74, Butrapet, S., Kinney, R. M. & Huang, C. Y. (2006). Determining genetic stabilities of chimeric dengue vaccine candidates based on dengue 2 PDK-53 virus by sequencing and quantitative TaqMAMA. J Virol Methods 131, 1 9. Cahour, A., Pletnev, A., Vazielle-Falcoz, M., Rosen, L. & Lai, C. J. (1995). Growth-restricted dengue virus mutants containing deletions in the 59 noncoding region of the RNA genome. Virology 207, Filomatori, C. V., Lodeiro, M. F., Alvarez, D. E., Samsa, M. M., Pietrasanta, L. & Gamarnik, A. V. (2006). A59RNA element promotes dengue virus RNA synthesis on a circular genome. Genes Dev 20, Gubler, D. J. (1998). Resurgent vector-borne diseases as a global health problem. Emerg Infect Dis 4, Guesdon, F. M., Greatorex, J., Rhee, S. R., Fisher, R., Hunter, E. & Lever, A. M. (2001). Sequences in the 59 leader of Mason-Pfizer monkey virus which affect viral particle production and genomic RNA packaging: development of MPMV packaging cell lines. Virology 288, Huang, C. Y., Butrapet, S., Pierro, D. J., Chang, G. J., Hunt, A. R., Bhamarapravati, N., Gubler, D. J. & Kinney, R. M. (2000). Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine. J Virol 74, Huang, C. Y., Butrapet, S., Tsuchiya, K. R., Bhamarapravati, N., Gubler, D. J. & Kinney, R. M. (2003). Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development. J Virol 77, Huang, C. Y., Silengo, S. J., Whiteman, M. C. & Kinney, R. M. (2005). Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus. J Virol 79, Kinney, R. M., Butrapet, S., Chang, G. J., Tsuchiya, K. R., Roehrig, J. T., Bhamarapravati, N. & Gubler, D. J. (1997). Construction of infectious cdna clones for dengue 2 virus: strain and its attenuated vaccine derivative, strain PDK-53. Virology 230, Kuhn, R. J., Zhang, W., Rossmann, M. G., Pletnev, S. V., Corver, J., Lenches, E., Jones, C. T., Mukhopadhyay, S., Chipman, P. R. & other authors (2002). Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108, Leitmeyer, K. C., Vaughn, D. W., Watts, D. M., Salas, R., Villalobos, I., de Chacon, Ramos, C. & Rico-Hesse, R. (1999). Dengue virus structural differences that correlate with pathogenesis. J Virol 73, Lindenbach, B. D. & Rice, C. M. (2003). Molecular biology of flaviviruses. Adv Virus Res 59, Miller, B. R. & Mitchell, C. J. (1986). Passage of yellow fever virus: its effect on infection and transmission rates in Aedes aegypti. Am J Trop Med Hyg 35, You, S., Falgout, B., Markoff, L. & Padmanabhan, R. (2001). In vitro RNA synthesis from exogenous dengue viral RNA templates requires long range interactions between 59- and 39-terminal regions that influence RNA structure. J Biol Chem 276, Zuker, M. (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31, Journal of General Virology 88
Fine Mapping of a cis-acting Sequence Element in Yellow Fever Virus RNA That Is Required for RNA Replication and Cyclization
JOURNAL OF VIROLOGY, Feb. 2003, p. 2265 2270 Vol. 77, No. 3 0022-538X/03/$08.00 0 DOI: 10.1128/JVI.77.3.2265 2270.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved. Fine Mapping
More informationPre-clinical Development of a Dengue Vaccine. Jeremy Brett Sanofi Pasteur, Singapore
Pre-clinical Development of a Dengue Vaccine Jeremy Brett Sanofi Pasteur, Singapore Dengue Vaccine B Guy 1 Talk flow Introduction: What are the challenges of dengue vaccine development? The Virus The host
More informationReceived 11 December 1995/Accepted 1 March 1996
JOURNAL OF VIROLOGY, June 1996, p. 3930 3937 Vol. 70, No. 6 0022-538X/96/$04.00 0 Copyright 1996, American Society for Microbiology Dengue Type 4 Virus Mutants Containing Deletions in the 3 Noncoding Region
More informationJoseph E. Blaney, Jr.,* Jennifer M. Matro, Brian R. Murphy, and Stephen S. Whitehead
JOURNAL OF VIROLOGY, May 2005, p. 5516 5528 Vol. 79, No. 9 0022-538X/05/$08.00 0 doi:10.1128/jvi.79.9.5516 5528.2005 Recombinant, Live-Attenuated Tetravalent Dengue Virus Vaccine Formulations Induce a
More informationConformational Changes in the Solution Structure of the Dengue Virus 5 End in the Presence and Absence of the 3 Untranslated Region
JOURNAL OF VIROLOGY, Jan. 2009, p. 1161 1166 Vol. 83, No. 2 0022-538X/09/$08.00 0 doi:10.1128/jvi.01362-08 Copyright 2009, American Society for Microbiology. All Rights Reserved. Conformational Changes
More informationBioinformation by Biomedical Informatics Publishing Group
Predicted RNA secondary structures for the conserved regions in dengue virus Pallavi Somvanshi*, Prahlad Kishore Seth Bioinformatics Centre, Biotech Park, Sector G, Jankipuram, Lucknow 226021, Uttar Pradesh,
More informationRole of RNA structures present at the 3VUTR of dengue virus on translation, RNA synthesis, and viral replication
Virology 339 (2005) 200 212 www.elsevier.com/locate/yviro Role of RNA structures present at the 3VUTR of dengue virus on translation, RNA synthesis, and viral replication Diego E. Alvarez, Ana Laura De
More informationNS1 Protein Expression in the JaOArS982 Strain of Japanese Encephalitis Virus Does Not Enhance Virulence in Mice
Tropical Medicine and Health Vol. 43 No.4, 2015, 233 237 doi: 10.2149/tmh.2015-27 Copyright 2015 by The Japanese Society of Tropical Medicine 233 Short Communications NS1 Protein Expression in the JaOArS982
More informationMODULE 5. Dengue. Edwin J. Asturias Associate Professor of Pediatrics Senior Investigator Director for Latin America
MODULE 5 Dengue Edwin J. Asturias Associate Professor of Pediatrics Senior Investigator Director for Latin America Symptoms of Dengue Fever Dengue: Skin rashes DHF manifestations Hemorrhages Thrombocytopenia
More informationInfectious clone construction of dengue virus type 2, strain Jamaican 1409, and characterization of a conditional E6 mutation
Journal of General Virology (2006), 87, 2263 2268 DOI 10.1099/vir.0.81958-0 Short Communication Infectious clone construction of dengue virus type 2, strain Jamaican 1409, and characterization of a conditional
More informationDengue Vaccine Butantan Institute. DCVMN, Bangkok, 2015
Dengue Vaccine Butantan Institute DCVMN, Bangkok, 2015 GENOME Dengue Viruses Dengue is a mosquito-borne RNA virus with 4 distinct serotypes: 1,2,3,and 4 3 structural proteins: C, prm, and E E protein is
More informationFlaviviruses New Challenges, New Vaccines
Flaviviruses New Challenges, New Vaccines Christian W. Mandl Institute of Virology Medical University of Vienna, AUSTRIA Family Flaviviridae Genus Hepacivirus Genus Pestivirus Genus Flavivirus (>70 members)
More informationCDC website:
Hepatitis B virus CDC website: http://www.cdc.gov/ncidod/diseases/hepatitis/slideset/hep_b/slide_1.htm Relevance Key Features es of Hepatitis t B Virus 250 million people infected worldwide. In areas of
More informationPart B. Nonclinical evaluation of dengue tetravalent vaccines (live, attenuated) 81
Annex 2 Guidelines on the quality, safety and efficacy of dengue tetravalent vaccines (live, attenuated) Replacement of Annex 1 of WHO Technical Report Series, No. 932 Abbreviations 55 Introduction 55
More informationExchange Program. Thailand. Mahidol University. Mahidol-Osaka Center for Infectious Diseases (MOCID) Date: 2013/06/05~2013/07/04
Exchange Program Thailand Mahidol University Mahidol-Osaka Center for Infectious Diseases (MOCID) Date: 2013/06/05~2013/07/04 Kobe University School of Medicine Faculty of Health Science Ueda Shuhei Introduction
More informationInfectious RNA transcribed from stably cloned full-length cdna of dengue type 4 virus
Proc. Nati. Acad. Sci. USA Vol. 88, pp. 5139-5143, June 1991 Medical Sciences Infectious RNA transcribed from stably cloned full-length cdna of dengue type 4 virus (dengue virus/infectious transcripts/virus
More informationHepatitis B Antiviral Drug Development Multi-Marker Screening Assay
Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay Background ImQuest BioSciences has developed and qualified a single-plate method to expedite the screening of antiviral agents against
More informationWhen infections go viral Zika Virus
When infections go viral Zika Virus John Fangman, MD Associate Professor of Medicine (Infectious Diseases) Senior Medical Director of Ambulatory, Medical College Physicians Medical College of Wisconsin
More informationGuidelines on the quality, safety and efficacy of dengue tetravalent vaccines (live, attenuated)
ENGLISH ONLY FINAL Guidelines on the quality, safety and efficacy of dengue tetravalent vaccines (live, attenuated) Proposed replacement of Annex 1 of WHO Technical Report Series, No. 932 World Health
More informationFrom Mosquitos to Humans: Genetic evolution of Zika Virus
Article: From Mosquitos to Humans: Genetic evolution of Zika Virus Renata Pellegrino, PhD Director, Sequencing lab Center for Applied Genomics The Children s Hospital of Philadelphia Journal Club Clinical
More informationReverse Genetics of RNA Viruses
Reverse Genetics of RNA Viruses Reverse Genetics (RG) he creation of a virus with a fulllength copy of the viral genome he most powerful tool in modern virology RG of RNA viruses Generation or recovery
More information7.012 Quiz 3 Answers
MIT Biology Department 7.012: Introductory Biology - Fall 2004 Instructors: Professor Eric Lander, Professor Robert A. Weinberg, Dr. Claudette Gardel Friday 11/12/04 7.012 Quiz 3 Answers A > 85 B 72-84
More informationChapter 5. Virus isolation and identification of measles and rubella in cell culture
Chapter 5. Virus isolation and identification of measles and rubella in cell culture In this chapter: 5.1. Recommended cell line for measles and rubella virus isolation 5.2. Propagation of Vero/hSLAM cells
More informationSupplementary Figure 1. SC35M polymerase activity in the presence of Bat or SC35M NP encoded from the phw2000 rescue plasmid.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Supplementary Figure 1. SC35M polymerase activity in the presence of Bat or SC35M NP encoded from the phw2000 rescue plasmid. HEK293T
More informationDerivation and Characterization of a Dengue Type 1 Host Range-Restricted Mutant Virus That Is Attenuated and Highly Immunogenic in Monkeys
JOURNAL OF VIROLOGY, Apr. 2002, p. 3318 3328 Vol. 76, No. 7 0022-538X/02/$04.00 0 DOI: 10.1128/JVI.76.7.3318 3328.2002 Derivation and Characterization of a Dengue Type 1 Host Range-Restricted Mutant Virus
More informationEssential Role of Cyclization Sequences in Flavivirus RNA Replication
JOURNAL OF VIROLOGY, July 2001, p. 6719 6728 Vol. 75, No. 14 0022-538X/01/$04.00 0 DOI: 10.1128/JVI.75.14.6719 6728.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Essential
More informationA Global Overview of the Chikungunya Virus Problem
A Global Overview of the Chikungunya Virus Problem Ann M. Powers, Ph.D. Division of Vector-Borne Infectious Diseases Centers for Disease Control and Prevention Chikungunya Virus Family Togaviridae,, genus
More informationChapter 5. Virus isolation and identification of measles and rubella in cell culture
Chapter 5. Virus isolation and identification of measles and rubella in cell culture In this chapter: 5.1 Recommended cell line for measles and rubella virus isolation 5.2 Propagation of Vero/hSLAM cells
More informationNOTES. The Naturally Attenuated Kunjin Strain of West Nile Virus Shows Enhanced Sensitivity to the Host Type I Interferon Response
JOURNAL OF VIROLOGY, June 2011, p. 5664 5668 Vol. 85, No. 11 0022-538X/11/$12.00 doi:10.1128/jvi.00232-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. NOTES The Naturally Attenuated
More informationDengue: The next vaccine preventable disease? Prof John McBride James Cook University
Dengue: The next vaccine preventable disease? Prof John McBride James Cook University Dengue viruses A flavivirus ~11kb genome, ~50nm diameter, lipid envelope. Gene order 5 C-prM-E-NS1 Four serotypes (1-4)
More informationMaterials and Methods , The two-hybrid principle.
The enzymatic activity of an unknown protein which cleaves the phosphodiester bond between the tyrosine residue of a viral protein and the 5 terminus of the picornavirus RNA Introduction Every day there
More informationImmune protection against dengue infection. Vaccine performance
Immune protection against dengue infection. Vaccine performance SCOTT B HALSTEAD MD Department of Preventive Medicine Uniformed Services University of the Health Sciences TOPICS Current dengue vaccines:
More informationCoronaviruses cause acute, mild upper respiratory infection (common cold).
Coronaviruses David A. J. Tyrrell Steven H. Myint GENERAL CONCEPTS Clinical Presentation Coronaviruses cause acute, mild upper respiratory infection (common cold). Structure Spherical or pleomorphic enveloped
More informationNASRONUDIN 4/17/2013. DENVs of each type are grouped into several genotypes.
NASRONUDIN Institute of Tropical Disease, Airlangga University-Tropical and Infectious Diseases Division, Department of Internal Medicine Medical Faculty-Dr. Soetomo Hospital Disampaikan pada 14 th Jakarta
More informationRama Nada. - Malik
- 2 - Rama Nada - - Malik 1 P a g e We talked about HAV in the previous lecture, now we ll continue the remaining types.. Hepatitis E It s similar to virus that infect swine, so its most likely infect
More informationZika Virus. It may be devastating, But we might just get one step ahead of it. Learning in Retirement Winter 2017 Daniel Burnside. photo: Newsweek.
Zika Virus It may be devastating, But we might just get one step ahead of it Learning in Retirement Winter 2017 Daniel Burnside photo: Newsweek.com INTRODUCTION TO VIRUSES STRUCTURE GENOME LIFE CYCLE
More informationDiagnostic Methods of HBV and HDV infections
Diagnostic Methods of HBV and HDV infections Zohreh Sharifi,ph.D Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine Hepatitis B-laboratory diagnosis Detection
More informationConstruction of Infectious cdna Clones for Dengue 2 Virus: Strain and Its Attenuated Vaccine Derivative, Strain PDK-53 1
VIROLOGY 230, 300 308 (1997) ARTICLE NO. VY978500 Construction of Infectious cdna Clones for Dengue 2 Virus: Strain 16681 and Its Attenuated Vaccine Derivative, Strain PDK-53 1 RICHARD M. KINNEY,*,2 SIRITORN
More informationWhat s Lurking out there??????
What s Lurking out there?????? Dave Warshauer, PhD, D(ABMM) Deputy Director, Communicable Diseases Wisconsin State Laboratory of Hygiene david.warshauer@slh.wisc.edu WISCONSIN STATE LABORATORY OF HYGIENE
More informationZIKA VIRUS. Epic and aspects of management
ZIKA VIRUS Epic and aspects of management Classification - Belong to the family Flaviviridae which are mosquitoes borne viruses such as Dengue virus ( DEN V ), West Nile virus ( WN V ), Yellow fever Virus
More informationEnvelope e_ :------, Envelope glycoproteins e_ ~ Single-stranded RNA ----, Nucleocapsid
Virus Antib(tdies Your Expertise, Our Antibodies, Accelerated Discovery. Envelope e_---------:------, Envelope glycoproteins e_-------1~ Single-stranded RNA ----, Nucleocapsid First identified in 1989,
More informationViral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP
Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP 1 Learning Objectives Recognize hazards associated with viral vectors in research and animal
More informationDengue and Zika vaccine development
Dengue and Zika vaccine development Carolyn E. Clark, PhD, MPH Scientist, Infection Control and Environmental Health Norwegian Institute of Public Health Kurs i import- og reisemedisin for helsepersonell
More informationZika Virus Infection in Cynomolgus Macaques
Zika Virus Infection in Cynomolgus Macaques Fusataka Koide Program Leader, Emerging Pathogens Background Mosquito-borne virus belonging to the flavivirus genus of the Flaviviridae family. Dengue viruses,
More informationWest Nile Virus. By Frank Riusech
West Nile Virus By Frank Riusech Disease Etiology: West Nile virus(wnv), genus, flavivirus is positive- stranded RNA arbovirus (arthropod- borne), belonging to the Flaviviridae family. Included in this
More informationA Novel in Vitro Replication System for Dengue Virus
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 274, No. 47, Issue of November 19, pp. 33714 33722, 1999 1999 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. A Novel in
More informationIdentification of Mutation(s) in. Associated with Neutralization Resistance. Miah Blomquist
Identification of Mutation(s) in the HIV 1 gp41 Subunit Associated with Neutralization Resistance Miah Blomquist What is HIV 1? HIV-1 is an epidemic that affects over 34 million people worldwide. HIV-1
More informationA trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4
Available online at www.sciencedirect.com R Virology 312 (2003) 222 232 www.elsevier.com/locate/yviro A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the
More informationDengue NS5 Global Consensus Sequence Development to Find Conserved Region for Antiviral Drug Development
Mol2Net, 2015, 1(Section B), pages 1-9, Proceedings 1 SciForum Mol2Net Dengue NS5 Global Consensus Sequence Development to Find Conserved Region for Antiviral Drug Development Shahid Mahmood 1,, Usman
More informationDengue Virus-Danger from Deadly Little Dragon
Molecular Medicine Dengue Virus-Danger from Deadly Little Dragon Dr.G.MATHAN Assistant Professor Department of Biomedical Science Bharathidasan University Tiruchirappalli, Tamil Nadu Vector (A carrier)
More informationReplication Defective Enterovirus Infections: Implications for Type I Diabetes
Replication Defective Enterovirus Infections: Implications for Type I Diabetes N. M. Chapman Department of Pathology & Microbiology University of Nebraska Medical Center Enterovirus Genome and 2 Capsid
More informationSECTION 25-1 REVIEW STRUCTURE. 1. The diameter of viruses ranges from about a. 1 to 2 nm. b. 20 to 250 nm. c. 1 to 2 µm. d. 20 to 250 µm.
SECTION 25-1 REVIEW STRUCTURE VOCABULARY REVIEW Define the following terms. 1. virus 2. capsid 3. retrovirus 4. viroid 5. prion MULTIPLE CHOICE Write the correct letter in the blank. 1. The diameter of
More informationDOI: /ICJ (Dengue fever) [2] (Aedes aegypti) (Aedes albopictus) (Dengue. (Flavivirus) 50 nm. ssrna) (capsid, C) ( ) (membrane, prm/m)
210 DOI: 10.6526/ICJ.2016.504 T (Dengue fever) [1] 128 39 [2] 4 5 21,000 [3] 3 1981 1987 1995 2014 [4] 2015 ( ) (Aedes aegypti) (Aedes albopictus) (Dengue virus) (Flaviviridae) (Flavivirus) 50 nm 11 kb
More informationB19, see Parvovirus B19 Bone marrow, gene transfer with parvovirus. Erythrovirus, see Parvovirus B19, Simian parvovirus
... Subject Index Adeno-associated virus Cap and genome encapsidation 87 DNA integration homologous recombination 90, 91 latency vs replication 77, 78 mechanism 79 requirements 78, 79 site in human genome
More informationLong-term Immunogenicity Following Vaccination with a New, Live-attenuated Vaccine Against Japanese Encephalitis (JE-CV)
Long-term Immunogenicity Following Vaccination with a New, Live-attenuated Vaccine Against Japanese Encephalitis (JE-CV) Sutee Yoksan, M.D., Ph.D. Center for Vaccine Development, Mahidol University Joint
More informationNature Medicine: doi: /nm.4322
1 2 3 4 5 6 7 8 9 10 11 Supplementary Figure 1. Predicted RNA structure of 3 UTR and sequence alignment of deleted nucleotides. (a) Predicted RNA secondary structure of ZIKV 3 UTR. The stem-loop structure
More informationFlavivirus Vaccines Japanese Encephalitis and Dengue
Flavivirus Vaccines Japanese Encephalitis and Dengue 14 th Advanced Vaccinology Course Veyrier du Lac, France May 16, 2012 Harold S. Margolis, MD Dengue Branch Centers for Disease Control and Prevention
More informationIII. What are the requirements for taking and passing this course?
1 Molecular Virology Lecture # 1: Course Introduction I. Instructor and Background Dr. Richard Kuhn rjkuhn@bragg.bio.purdue.edu B-129 Lilly Hall 494-1164 Office Hours - Wednesday 10:30-11:30 II. Objective:
More informationEvaluation of platforms to detect Zika and West Nile virus from honeycards
059 - Evaluation of platforms to detect Zika and West Nile virus from honeycards in Florida PI: Nathan Burkett-Cadena Florida Medical Entomology Laboratory University of Florida IFAS 00 9 th St. SE Vero
More informationStructural and Functional Elements of the Promoter Encoded by the 5 Untranslated Region of the Venezuelan Equine Encephalitis Virus Genome
JOURNAL OF VIROLOGY, Sept. 2009, p. 8327 8339 Vol. 83, No. 17 0022-538X/09/$08.00 0 doi:10.1128/jvi.00586-09 Copyright 2009, American Society for Microbiology. All Rights Reserved. Structural and Functional
More informationVirus evolution during a severe dengue epidemic in Cuba, 1997 $
Virology 334 (2005) 154 159 Rapid Communication Virus evolution during a severe dengue epidemic in Cuba, 1997 $ Rosmari Rodriguez-Roche a, Mayling Alvarez a, Tamara Gritsun b, Scott Halstead c, Gustavo
More informationWORLD HEALTH ORGANIZATION. Smallpox eradication: destruction of Variola virus stocks
WORLD HEALTH ORGANIZATION EXECUTIVE BOARD EB111/5 111th Session 23 December 2002 Provisional agenda item 5.3 Smallpox eradication: destruction of Variola virus stocks Report by the Secretariat 1. The WHO
More informationChapter 19: Viruses. 1. Viral Structure & Reproduction. 2. Bacteriophages. 3. Animal Viruses. 4. Viroids & Prions
Chapter 19: Viruses 1. Viral Structure & Reproduction 2. Bacteriophages 3. Animal Viruses 4. Viroids & Prions 1. Viral Structure & Reproduction Chapter Reading pp. 393-396 What exactly is a Virus? Viruses
More informationZIKA VIRUS. John J. Russell MD May 27, 2016
John J. Russell MD May 27, 2016 HISTORY Discovered 1947 Zika Forest of Uganda in rhesus monkeys, thus the name Found in humans in Africa in 1952 Not considered a public health threat until outbreak in
More informationStudy of Sequence Variation of Dengue Type 3 Virus in Naturally Infected Mosquitoes and Human Hosts: Implications for Transmission and Evolution
JOURNAL OF VIROLOGY, Nov. 2004, p. 12717 12721 Vol. 78, No. 22 0022-538X/04/$08.00 0 DOI: 10.1128/JVI.78.22.12717 12721.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved. Study
More informationCoronaviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics
Coronaviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Virion Spherical enveloped particles studded with clubbed spikes Diameter 120-160 nm Coiled helical
More informationWest Nile Virus. Family: Flaviviridae
West Nile Virus 1 Family: Flaviviridae West Nile Virus Genus: Flavivirus Japanese Encephalitis Antigenic Complex Complex Includes: Alfuy, Cacipacore, Japanese encephalitis, koutango, Kunjin, Murray Valley
More informationModule Three About Zika Virus: What is Known and Not Known
Module Three About Zika Virus: What is Known and Not Known HOUSEKEEPING For educational and quality improvement purposes, this TeleECHO Clinic will be recorded By participating in this clinic, you are
More informationDENGUE AND BLOOD SAFETY. Ester C Sabino, MD, PhD Dep. of Infectious Disease/Institute of Tropical Medicine University of São Paulo
DENGUE AND BLOOD SAFETY Ester C Sabino, MD, PhD Dep. of Infectious Disease/Institute of Tropical Medicine University of São Paulo Dengue virus Arbovirus (arthropod-borne virus) virus transmitted by mosquitoes:
More informationChapter 14 Part One Biotechnology and Industry: Microbes at Work
Chapter 14 Part One Biotechnology and Industry: Microbes at Work Objectives: After reading Chapter 14, you should understand How biotechnology has resulted in numerous pharmaceutical products to help lessen
More informationChapter 19: Viruses. 1. Viral Structure & Reproduction. What exactly is a Virus? 11/7/ Viral Structure & Reproduction. 2.
Chapter 19: Viruses 1. Viral Structure & Reproduction 2. Bacteriophages 3. Animal Viruses 4. Viroids & Prions 1. Viral Structure & Reproduction Chapter Reading pp. 393-396 What exactly is a Virus? Viruses
More informationZika Virus. Centers for Disease Control and Prevention
Centers for Disease Control and Prevention Zika Virus Ingrid Rabe Medical Epidemiologist Arboviral Diseases Branch Centers for Disease Control and Prevention February 1, 2016 Zika Virus Single stranded
More informationEpidemiology and entomology of the Zika virus outbreak
Epidemiology and entomology of the Zika virus outbreak M A T T H E W B A Y L I S I N S T I T U T E O F I N F E C T I O N A N D G L O B A L H E A L T H U N I V E R S I T Y O F L I V E R P O O L Zika in
More informationDengue in Jeddah, Saudi Arabia,
by Mazen Fakeeh and Ali M Zaki Virus Laboratory, Dr Solimon Fakeeh Hospital, Jeddah, Saudi Arabia Abstract Dengue virus (DEN-2) was first isolated from a fatal case of dengue haemorrhagic fever (DHF) in
More informationDevelopment and Application of a Novel Attenuated Live Japanese Encephalitis Vaccine SA
Development and Application of a Novel Attenuated Live Japanese Encephalitis Vaccine SA14-14-2 Yu Yongxin (National Institute for the Control of Pharmaceutical and Biological Products, Beijing 100050,
More informationSupplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR
Supplemental Materials and Methods Plasmids and viruses To generate pseudotyped viruses, the previously described recombinant plasmids pnl4-3-δnef-gfp or pnl4-3-δ6-drgfp and a vector expressing HIV-1 X4
More informationOutbreaks of Zika Virus: What Do We Know? Presented by Dr Jonathan Darbro Mosquito Control Lab, QIMR Berhgofer 15 September 2016
Outbreaks of Zika Virus: What Do We Know? Presented by Dr Jonathan Darbro Mosquito Control Lab, QIMR Berhgofer 15 September 2016 Overview History Distribution Modes of Transmission Symptoms Some Causal
More informationRecombinant Protein Expression Retroviral system
Recombinant Protein Expression Retroviral system Viruses Contains genome DNA or RNA Genome encased in a protein coat or capsid. Some viruses have membrane covering protein coat enveloped virus Ø Essential
More informationNON HUMAN PRIMATE BIOMEDICAL RESEARCH FOR TACKLING EMERGING INFECTIOUS DISEASES (II): ZIKA VIRUS. Special series on Laboratory Animal Science
NON HUMAN PRIMATE BIOMEDICAL RESEARCH FOR TACKLING EMERGING INFECTIOUS DISEASES (II): ZIKA VIRUS Special series on Laboratory Animal Science SPECIAL SERIES ON LABORATORY ANIMAL SCIENCE Signature by Adriano
More informationDengue Vaccine. Irani Ratnam The Royal Melbourne Hospital & Peter Doherty Institute
Dengue Vaccine Irani Ratnam The Royal Melbourne Hospital & Peter Doherty Institute No Conflicts of interest Dengue Dengue virus (DENV), a member of the genus Flavivirus Vector-borne disease transmitted
More informationHepatitis C in Australia:
Hepatitis C in Australia: Epidemiology and Clinical Presentation (and a bit of virology ) A/Prof Mark Douglas Hepatitis C - Distribution Te and Jensen 2010 Clin Liver Dis Hepatitis C Epidemiology Estimated
More informationNEXT GENERATION SEQUENCING OPENS NEW VIEWS ON VIRUS EVOLUTION AND EPIDEMIOLOGY. 16th International WAVLD symposium, 10th OIE Seminar
NEXT GENERATION SEQUENCING OPENS NEW VIEWS ON VIRUS EVOLUTION AND EPIDEMIOLOGY S. Van Borm, I. Monne, D. King and T. Rosseel 16th International WAVLD symposium, 10th OIE Seminar 07.06.2013 Viral livestock
More informationKlaus K. Orlinger, Verena M. Hoenninger, Regina M. Kofler, and Christian W. Mandl*
JOURNAL OF VIROLOGY, Dec. 2006, p. 12197 12208 Vol. 80, No. 24 0022-538X/06/$08.00 0 doi:10.1128/jvi.01540-06 Copyright 2006, American Society for Microbiology. All Rights Reserved. Construction and Mutagenesis
More informationSome living things are made of ONE cell, and are called. Other organisms are composed of many cells, and are called. (SEE PAGE 6)
Section: 1.1 Question of the Day: Name: Review of Old Information: N/A New Information: We tend to only think of animals as living. However, there is a great diversity of organisms that we consider living
More informationLecture 2: Virology. I. Background
Lecture 2: Virology I. Background A. Properties 1. Simple biological systems a. Aggregates of nucleic acids and protein 2. Non-living a. Cannot reproduce or carry out metabolic activities outside of a
More informationDepartment of Microbiology, Faculty of Science, Mahidol University, Bangkok; 2
GENETIC DIFFERENCES OF E GENE OF A THAI STRAIN OF JAPANESE ENCEPHALITIS VIRUS THAT DETERMINE SMALL PLAQUE SIZE PHENOTYPE BUT NOT NEUROVIRULENCE IN SUCKLING MICE Sasithorn Lorroengsil 1,2, Antony Chen 3,
More informationDengue & Chikungunya In Asia Strategies for Testing
Dengue & Chikungunya In Asia Strategies for Testing Sally Lam Blood Services Group Health Sciences Authority Singapore 1 The Viruses - Arboviruses Flavivirus DENGUE Enveloped virus, ~50 nm in diameter
More informationVirus Genetic Diversity
Virus Genetic Diversity Jin-Ching Lee, Ph.D. 李 jclee@kmu.edu.tw http://jclee.dlearn.kmu.edu.t jclee.dlearn.kmu.edu.tw TEL: 2369 Office: N1024 Faculty of Biotechnology Kaohsiung Medical University Outline
More informationDengue-2 Vaccine: Viremia and Immune Responses in Rhesus Monkeys
INFECTION AND IMMUNITY, Jan. 1980, p. 181-186 0019-9567/80/01-0181/06$02.00/0 Vol. 27, No. 1 Dengue-2 Vaccine: Viremia and Immune Responses in Rhesus Monkeys ROBERT McN. SCOTT,'t* ANANDA NISALAK,' KENNETH
More informationELISA as an alternative tool for epidemiological surveillance for dengue in mosquitoes: a report from Thailand
J Vector Borne Dis 44, December 2007, pp. 272 276 ELISA as an alternative tool for epidemiological surveillance for dengue in mosquitoes: a report from Thailand Mayuna Srisuphanunt a, Ratana Sithiprasasna
More informationMutants and HBV vaccination. Dr. Ulus Salih Akarca Ege University, Izmir, Turkey
Mutants and HBV vaccination Dr. Ulus Salih Akarca Ege University, Izmir, Turkey Geographic Distribution of Chronic HBV Infection 400 million people are carrier of HBV Leading cause of cirrhosis and HCC
More informationVirion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics
Hepadnaviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Hepatitis viruses A group of unrelated pathogens termed hepatitis viruses cause the vast majority
More informationSuccessful Propagation of Flavivirus Infectious cdnas by a Novel Method to Reduce the
JVI Accepts, published online ahead of print on 1 January 0 J. Virol. doi:./jvi.01- Copyright 0, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved. 1 Successful
More information! " ## $%& &'( ) Page 1 of 7
! " ## $%& &'( ) *+, -+.//0 Page 1 of 7 Introduction This report reflects the discussion and conclusions of a group of experts on regulatory aspects of vaccines from national and international regulatory
More informationUpdated Questions and Answers related to the dengue vaccine Dengvaxia and its use
WHO Secretariat Updated Questions and Answers related to the dengue vaccine Dengvaxia and its use Published 22 December 2017 This document takes into account new and unpublished data that were communicated
More informationIn the Name of God. Talat Mokhtari-Azad Director of National Influenza Center
In the Name of God Overview of influenza laboratory diagnostic technology: advantages and disadvantages of each test available Talat Mokhtari-Azad Director of National Influenza Center Tehran- Iran 1 1)
More informationIntroduction to the Impact of Resistance in Hepatitis C
Introduction to the Impact of Resistance in Hepatitis C Sponsored by AbbVie 2/1/2017 Presented by Sammy Saab, MD, MPH, FACG, AGAF, FAASLD February 1 st, 2017 1 AbbVie disclosures This is an Abbvie sponsored
More informationIntroduction retroposon
17.1 - Introduction A retrovirus is an RNA virus able to convert its sequence into DNA by reverse transcription A retroposon (retrotransposon) is a transposon that mobilizes via an RNA form; the DNA element
More informationThe Features of Imported Dengue Fever Cases Confirmed at National Institute of Infectious Diseases Japan, during p
The Features of Imported Dengue Fever Cases Confirmed at National Institute of Infectious Diseases Japan, during 2001 +p by Ken-Ichiro Yamada* #, Tomohiko Takasaki*, Masaru Nawa**, Reiko Nerome*, Yohko
More information